A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study.

Makoto KuboMasaaki KawaiHiraku KumamaruHiroaki MiyataKenji TamuraMasayuki YoshidaEtsuyo OgoMasayuki NagahashiSota AsagaYasuyuki KojimaTakayuki KadoyaKenjiro AogiNaoki NiikuraMinoru MiyashitaKotaro IijimaNaoki HayashiYutaka YamamotoShigeru ImotoHiromitsu Jinno

Published in: Breast cancer research and treatment (2019)

NCD data revealed that systemic treatment improved OS in pT1bc but not in pT1a node-negative HER2+ breast cancer patients. Future observational research using big-sized data is expected to play an important role in optimizing treatment for patients with early-stage breast cancer.

Keyphrases

early stage
big data
lymph node
electronic health record
emergency department
squamous cell carcinoma
combination therapy
quality improvement
single cell
young adults
replacement therapy
deep learning
smoking cessation
free survival
breast cancer risk